Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

M. De Santis; J. Bellmunt; G. Mead; J.M. Kerst; Michael Leahy; P. Maroto; T. Gil; S. Marreaud; G. Daugaard; I. Skoneczna; S. Collette; J. Lorent; R. De Wit; R. Sylvester

doi:10.1200/JCO.2011.37.3571

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

M. De Santis, J. Bellmunt, G. Mead, J.M. Kerst, Michael Leahy, P. Maroto, T. Gil, S. Marreaud, G. Daugaard, I. Skoneczna, S. Collette, J. Lorent, R. De Wit, R. Sylvester

Research output: Contribution to journal › Review article

314 Citations (Scopus)

Original language	English
Pages (from-to)	191-199
Journal	Journal of Clinical Oncology
Volume	30
Issue number	2
DOIs	https://doi.org/10.1200/JCO.2011.37.3571
Publication status	Published - 2012

Access to Document

10.1200/JCO.2011.37.3571

Cite this

De Santis, M., Bellmunt, J., Mead, G., Kerst, J. M., Leahy, M., Maroto, P., Gil, T., Marreaud, S., Daugaard, G., Skoneczna, I., Collette, S., Lorent, J., De Wit, R., & Sylvester, R. (2012). Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. Journal of Clinical Oncology, 30(2), 191-199. https://doi.org/10.1200/JCO.2011.37.3571

De Santis, M. ; Bellmunt, J. ; Mead, G. ; Kerst, J.M. ; Leahy, Michael ; Maroto, P. ; Gil, T. ; Marreaud, S. ; Daugaard, G. ; Skoneczna, I. ; Collette, S. ; Lorent, J. ; De Wit, R. ; Sylvester, R. / Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. In: Journal of Clinical Oncology. 2012 ; Vol. 30, No. 2. pp. 191-199.

@article{b138f28ca4cf4a579458823835bbb22b,

title = "Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.",

author = "{De Santis}, M. and J. Bellmunt and G. Mead and J.M. Kerst and Michael Leahy and P. Maroto and T. Gil and S. Marreaud and G. Daugaard and I. Skoneczna and S. Collette and J. Lorent and {De Wit}, R. and R. Sylvester",

year = "2012",

doi = "10.1200/JCO.2011.37.3571",

language = "English",

volume = "30",

pages = "191--199",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "2",

}

De Santis, M, Bellmunt, J, Mead, G, Kerst, JM, Leahy, M, Maroto, P, Gil, T, Marreaud, S, Daugaard, G, Skoneczna, I, Collette, S, Lorent, J, De Wit, R & Sylvester, R 2012, 'Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.', Journal of Clinical Oncology, vol. 30, no. 2, pp. 191-199. https://doi.org/10.1200/JCO.2011.37.3571

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. / De Santis, M.; Bellmunt, J.; Mead, G.; Kerst, J.M.; Leahy, Michael; Maroto, P.; Gil, T.; Marreaud, S.; Daugaard, G.; Skoneczna, I.; Collette, S.; Lorent, J.; De Wit, R.; Sylvester, R.

In: Journal of Clinical Oncology, Vol. 30, No. 2, 2012, p. 191-199.

Research output: Contribution to journal › Review article

TY - JOUR

T1 - Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

AU - De Santis, M.

AU - Bellmunt, J.

AU - Mead, G.

AU - Kerst, J.M.

AU - Leahy, Michael

AU - Maroto, P.

AU - Gil, T.

AU - Marreaud, S.

AU - Daugaard, G.

AU - Skoneczna, I.

AU - Collette, S.

AU - Lorent, J.

AU - De Wit, R.

AU - Sylvester, R.

PY - 2012

Y1 - 2012

U2 - 10.1200/JCO.2011.37.3571

DO - 10.1200/JCO.2011.37.3571

M3 - Review article

C2 - 22162575

VL - 30

SP - 191

EP - 199

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

SN - 0732-183X

IS - 2

ER -

De Santis M, Bellmunt J, Mead G, Kerst JM, Leahy M, Maroto P et al. Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. Journal of Clinical Oncology. 2012;30(2):191-199. https://doi.org/10.1200/JCO.2011.37.3571